🧠Just back from Barcelona and buzzing with insights from #ECTRIMS2025! Over 9000 experts, 1800 posters & 150 oral sessions—this year’s congress was packed with breakthroughs.
📖 www.fortrea.com/insights/multiple-sclero...
#Neuroscience #ClinicalTrials
Gregory Wu stands in front of a scientific poster titled "The Role of B Cell and Microglial BTK Signaling in the Pathogenesis of Experimental Autoimmune Encephalomyelitis."
Gregory Wu, MD, PhD, presented a poster at #ECTRIMS2025 titled, "The Role of B Cell and Microglial BTK Signaling in the Pathogenesis of Experimental Autoimmune Encephalomyelitis." Several others from our #MS group presented at the meeting, as well!
. #MRI Research Shows ‘Virtually Complete Abrogation’ of New Lesions with Switch to Ofatumumab for #MultipleSclerosis Patients
www.diagnosticimaging.com/view/mri-res...
#radiology #neuroradiology #ECTRIMS2025
Ocrelizumab (Ocrevus) delayed overall disability progression and worsening of upper limb function in people with primary progressive #MultipleSclerosis over 144 weeks, the ORATORIO-HAND trial showed. #ECTRIMS2025
www.medpagetoday.com/meetingcoverage/ectrims/...
Back from #ECTRIMS2025 in Barcelona! Where Claudia Rodriguez-Lopez masterfully presented our work “Progressive demyelination, neuroinflammation and disability by brain TAF1 alteration found in #multiple_sclerosis”, selected for Best of ECTRIMS Slide Deck!
@cbm-csic-uam.bsky.social
@uam.es @csic.es
Multiple sclerosis patients treated with ocrelizumab (Ocrevus) had a higher risk of infections over time than other MS patients, a real-world cohort study showed. #ECTRIMS2025
www.medpagetoday.com/meetingcoverage/ectrims/...
Last week I was fortunate to participate the world's largest #MultipleSclerosis conference #ECTRIMS2025 What an astonishing experience! Three days in lovely #Barcelona with more than 9600 participants! 🤩 ectrims.eu/ectrims2025/
Dr Yuan Zhou, Dr Chhavi Asthana, Dr Xin Lin, Professor Bruce Taylor, and Panteha Khaledi of the Menzies Institute for Medical Research MS Research Flagship in a group photo with other EBV-MS consortium members at ECTRIMS 2025 in Barcelona
👏Proud to see our MS Research Flagship researchers contribute to the EBV-MS consortium meeting at #ECTRIMS2025 in Barcelona—sharing ideas, bringing the Australian perspective, building global connections & advancing research into EBV’s role in MS.
#MSResearch #EBV #MSAustralia #GlobalCollaboration
Pregnancy was not linked with long-term disability outcomes in women with moderately severe multiple sclerosis (MS), registry data suggested. #ECTRIMS2025
www.medpagetoday.com/meetingcoverage/ectrims/...
Investigational vidofludimus calcium missed its primary target in an exploratory phase II study of progressive multiple sclerosis but showed promising disability-related trends, data from the CALLIPER trial suggested. #ECTRIMS2025
www.medpagetoday.com/meetingcoverage/ectrims/...
Physical activity was associated with a lower risk of disability progression in multiple sclerosis, longitudinal data showed. #ECTRIMS2025
www.medpagetoday.com/meetingcoverage/ectrims/...
#ECTRIMS2025 has been fantastic. Particularly enjoyed meeting these fab members of the All-Ireland MS Research Network (AIMS-RN), a stimulating, multidisciplinary Irish #MS clinical research community ✨️
Ideas sparked & plans for collaboration! 🙌🧠
aims-rn.org
Amazing location (Maritime Museum of Barcelona), wonderful atmosphere, great people! Our group enjoyed getting to relax and interact with others from the #MultipleSclerosis research community at the #ECTRIMS2025 Party. 🥳
@aiprognosis.bsky.social partner NeuroTransData attended ECTRIMS 2025 – the leading MS research congress.
A great occasion to network and raise visibility for the AI-PROGNOSIS project in the wider neurodegeneration and digital health community.
#ECTRIMS2025 #ResearchCollaboration
Day 3 of #ECTRIMS2025
extension results for ravulizumab in NMO disease (AQP4+). 0 relapses in 105 patient years! absolutely incredible efficacy!
Dr Yi Chao Foong of the MS Research Flagship at Menzies Institute for Medical Research in Tasmania, Australia presents his scientific poster at the 2025 ECTRIMS Congress in Barcelona, Spain.
Can high-efficacy treatments improve outcomes for people diagnosed with #MultipleSclerosis later in life? Dr Yi Chao Foong @ycfoong.bsky.social from our #MSResearch Flagship explores this in his poster at #ECTRIMS2025
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
Chhavi Asthana of the MS Research Flagship at Menzies Institute for Medical Research in Tasmania, Australia presents her scientific poster at the 2025 ECTRIMS Congress in Barcelona, Spain.
What impact do #MultipleSclerosis treatments, particularly B cell therapies, have on Epstein-Barr virus activity? Our MS Research Flagship's Dr Chhavi Asthana presents her poster investigating that @ #ECTRIMS2025 🔗msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MSResearch
Panteha Khaledi of the MS Research Flagship at Menzies Institute for Medical Research in Tasmania, Australia presents her scientific poster at the 2025 ECTRIMS Congress in Barcelona, Spain.
Panteha Khaledi of the MS Research Flagship at Menzies Institute for Medical Research in Tasmania, Australia presents her scientific poster at the 2025 ECTRIMS Congress in Barcelona, Spain.
Our MS Research Flagship's Panteha Khaledi presents her poster at #ECTRIMS2025! Her study explores how the immune system’s T cells respond to Epstein-Barr virus (EBV) in people with #MultipleSclerosis
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MSResearch
It's been fab to bring #neuropsychology research from @svuh.bsky.social to #ECTRIMS2025 👌 with @fiokeeffe.bsky.social
Shout out to Laura Davenport and Lauren Costello for their research and work on some super posters 🙌
Delighted with the emphasis on cognition and wellbeing at #ECTRIMS2025 🙌
It's been an amazing learning opportunity so far as well as a great forum for sharing ideas and meeting clinicians and researchers from Europe and around the world who are passionate about supporting people living with #MS ✨️
Highlights from day 2 at #ECTRIMS2025 📸
Muriel, Maria and @katrinpape.bsky.social enjoying the chance to present their work. #iWiMS
Research from ECTRIMS 2025 suggests the MIND diet may reduce physical disability and fatigue in MS. A graphic of assorted food is positioned below the text. "MultipleSclerosisNewsToday.com." is noted as source at bottom.
How might a diet focusing on brain health help in MS? Findings out of #ECTRIMS2025 offer some clues: https://bit.ly/4nFa3cF
#MS #MultipleSclerosis #MSResearch #MSDiet #MSCommunity #LivingWithMS #MSNews #Bionews
Effect of rTMS + RHB on Brain Functional Connectivity in #MS.
Poster #idi #ectrims2025 #rims2025 in BCN.
@iguttmann.bsky.social @cemcat-12em.bsky.social #idi @vallhebron.com @jaumesastregarriga.bsky.social @raulpelayo.bsky.social
#ECTRIMS2025. only 50% of MS patients are up to date vaccines. Inactivated vaccines are NOT associated with relapses and are safe to take in MS. Vaccines are a safe way to reduce infection risk on DMTs. live vaccines may be contraindicated on tx but Can be given 4 weeks before DMT initiation.
Imaging in chronic inflammation session at #ECTRIMS2025 was quite interesting. Several abstracts looking at associations between choroid plexus size and PIRA and chronic active MS lesions. A future easily accessible progressive MS biomarker? #multiplesclerosis
Adam Cartwright presents preclinical data today at #ECTRIMS2025 suggesting MRT-6160, a first-in-class VAV1-directed MGD, has the potential to benefit patients with neuroinflammatory diseases as well as other T- and B-cell immune-mediated conditions: bit.ly/3KEi7vf
🎉 What a whirlwind first day at #ECTRIMS2025 in Barcelona!
The Register team has been incredibly busy – sharing our research, connecting with global MS experts, and showcasing how patient-powered data is driving real change.
📊 Huge thank you to everyone who has stopped by our stand (N14) so far!
If you're at #ECTRIMS2025, come and visit me at my poster today: P655 Ageing-related immune signatures in mutiple sclerosis.
And please also check out other highlights from our group @neurologymainz.bsky.social!
We're excited for another great day at #ECTRIMS2025!
In the Free Communications 6 session (11:15-12:30 Lecture Hall 117), Muriel Schraad will present her talk entitled "Choroid plexus enlargement associates with serum neurofilament and predicts relapse-free progression in #MultipleSclerosis. More👇
Himanshu Saraswat of the MS Research Flagship at Menzies Institute for Medical Research in Tasmania, Australia standing with his poster for his research abstract at the 2025 ECTRIMS Congress in Barcelona, Spain.
Our MS Research Flagship's Himanshu Saraswat is at #ECTRIMS2025! His study investigated whether rare genetic variants in families with multiple MS cases could help explain MS risk.
More 👇
🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025
#MultipleSclerosis #MSResearch
